Doxorubicin Accord 100 mg/50 ml, Injektionslösung
7680687460040
CH-68746
Injektionslösung
Associated product:
DOXORUBICIN Accord sol inj 100 mg/50ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
177.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 136.70
Specialties list
Yes
Generic
Yes
SL addition date:
01/06/2025
Compulsory until:
31/03/2024
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68746
- Drug name
- Doxorubicin Accord, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01DB01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 14/07/2022
- Authorization expiration date
- 13/07/2027
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- DOXORUBICIN Accord sol inj 100 mg/50ml flac
- Description (DE)
- DOXORUBICIN Accord Inj Lös 100 mg/50ml Durchstf
- Market launch
- 14/07/2022
- Narcotic (BTM)
- No
Original drug
Adriblastin RD, Injektionspräparat
GTIN: 7680503570151
CHF 32.10